IPO - HELIUS MEDICAL TECHNOLOGIES, INC.

Form Type: S-1

Filing Date: 2025-05-23

Corporate Action: Ipo

Type: New

Accession Number: 000110465925052494

Filing Summary: On May 23, 2025, Helius Medical Technologies, Inc. filed a Form S-1 with the SEC related to a public offering of 3,448,275 shares of Class A common stock and accompanying common warrants. The registration includes up to 7,068,963 shares potentially issuable upon exercise of pre-funded and common warrants. A reverse stock split approved by stockholders was also finalized, converting shares at a ratio of 1-for-15. The company has received various approvals concerning stock splits, authorized shares, and compensation plans. The process is part of preparing for a public offering following compliance with Nasdaq’s minimum listing requirements. The offering price and terms are to be determined based on market conditions at pricing. The proceeds will support ongoing developments and are expected to have implications on share ownership and market activities.

Form Type: DRS

Filing Date: 2025-04-15

Corporate Action: Ipo

Type: New

Accession Number: 000110465925035130

Filing Summary: Helius Medical Technologies, Inc. has filed a draft registration statement (DRS) with the SEC for an initial public offering (IPO) of its securities. This includes shares of Class A common stock and warrants. The registration indicates a focus on offering pre-funded warrants to certain purchasers to circumvent ownership limitations. The last reported sale price of Helius' common stock prior to the offering was $0.30 per share. The document also outlines the implications of being classified as a smaller reporting company, with associated reporting benefits. Additionally, it details compliance issues with Nasdaq, including a failure to meet minimum bid price and stockholders’ equity requirements, and outlines the timelines for regaining compliance. The registration is filed as a confidential document and does not constitute a public offer yet.